Name | kangai 1 (suppression of tumorigenicity 6, prostate; CD82 antigen (R2 leukocyte antigen, antigen detected by monoclonal and antibody IA4)) |
Symbol | KAI1 |
Aliases | R2; 4F9; C33; IA4; ST6; CD82; GR15; SAR2; CD82 antigen; R2 leukocyte antigen; suppressor of tumorigenicity 6 |
Gene Product | |
Category | - Gross deletion in Prostate cancer
- Methylation in Prostate cancer
- Mutation in Prostate cancer
|
UniGene | Hs.323949 |
OMIM | 600623 |
Locus | 3732 |
Summary | This metastasis suppressor gene product is a membrane glycoprotein that is a member of the transmembrane 4 superfamily. Expression of this gene has been shown to be downregulated in tumor progression of human cancers and can be activated by p53 through a consensus binding sequence in the promoter. Its expression and that of p53 are strongly correlated, and the loss of expression of these two proteins is associated with poor survival for prostate cancer patients. |
Gene Ontology | |
Expression | EST (252 ESTs, 117 libraries) |
Tissue ? |
Frequency ? |
Count ? |
adipose (1/10) | | 1/2445 |
adrenal gland (1/15) | | 1/17521 |
b cells (1/1) | | 14/16734 |
blood (2/27) | | 7/40686 |
bone (1/13) | | 1/26211 |
brain (11/204) | | 13/362011 |
cartilage (1/5) | | 1/11018 |
colon (6/853) | | 33/165626 |
embryo (1/19) | | 4/37976 |
esophagus (1/6) | | 1/3022 |
eye (1/33) | | 1/93836 |
foreskin (1/4) | | 2/20040 |
germ cell (1/7) | | 1/57383 |
head and neck (7/990) | | 10/79796 |
intestine (1/4) | | 1/11528 |
kidney (6/86) | | 15/132968 |
lung (7/312) | | 17/245386 |
muscle (2/21) | | 11/71297 |
oral cavity (1/18) | | 2/44567 |
ovary (5/144) | | 7/81880 |
pancreas (7/33) | | 19/117255 |
parathyroid (1/4) | | 7/19377 |
placenta (4/342) | | 11/157762 |
prostate (3/291) | | 6/109871 |
skin (6/31) | | 11/100815 |
spleen (1/7) | | 1/9511 |
stomach (5/312) | | 11/129930 |
testis (1/171) | | 2/117531 |
thyroid (1/24) | | 1/6853 |
uncharacterized tissue (23/1773) | | 28/713325 |
uterus (7/212) | | 12/155110 |
|
SAGE (10371191 tags, 193 libraries) |
Tissue ? |
Frequency ? |
Count ? |
brain (17/19) | | 45/2113680 |
cerebellum (1/1) | | 4/205120 |
colon (7/8) | | 18/789162 |
eye (4/6) | | 15/863677 |
heart (1/1) | | 6/168714 |
kidney (1/2) | | 3/125571 |
liver (1/1) | | 5/133722 |
lung (1/1) | | 6/267429 |
mammary gland (12/19) | | 90/1001838 |
muscle (2/2) | | 3/161581 |
ovary (8/10) | | 71/521405 |
pancreas (7/8) | | 72/510942 |
prostate (11/13) | | 24/1139230 |
skin (2/7) | | 2/37633 |
stomach (2/3) | | 8/409395 |
uncharacterized tissue (14/22) | | 45/1367264 |
vascular (3/3) | | 12/554828 |
|
|
SNP | rs2115665 (A/G:intron);  rs883752 (C/T:coding-nonsyn);  rs934175 (A/G:locus-region);  rs2082053 (T/C:mrna-utr);  rs744630 (C/G:mrna-utr);  rs2863106 (A/G:intron);  rs1344709 (A/G:mrna-utr);  rs2115670 (G/T:mrna-utr);  rs3051240 (-/TTTTT:intron);  rs1981992 (C/G:mrna-utr);  rs891307 (C/T:intron);  rs891303 (A/G:intron);  rs1560296 (A/G:mrna-utr);  rs730129 (C/T:mrna-utr);  rs891305 (C/T:mrna-utr);  rs1864297 (A/T:mrna-utr);  rs2303861 (T/C:coding-nonsyn);  rs2163094 (C/G:mrna-utr);  rs2099140 (C/T:mrna-utr);  rs2902412 (C/G:mrna-utr);  rs919444 (C/T:intron);  rs744222 (A/C:mrna-utr);  rs1063031 (G/A:mrna-utr);   |
Evidence | Gross deletion in Prostate cancer
Methylation in Prostate cancer
Mutation in Prostate cancer
|